To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures

Pfizer

Status and phase: Completed; Phase 3

Conditions: Seizure Disorder, Partial

Treatments: Drug: Pregabalin

Study type: Interventional

Funder types: Industry

Identifiers

NCT00141388

1008-010

Details and patient eligibility

About

To evaluate the long-term safety and efficacy of pregabalin in patients with partial seizures.

Enrollment: 455 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Must have met the inclusion criteria for the preceding double-blind study
• Have received double-blind study medication and wish to receive open-label pregabalin.

Exclusion criteria

• Cannot have absence seizures.

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)